Anew Medical, Inc. - WENA Book Capitalization

Anew Medical, Inc. (WENA) is establishing a closed network of clinics centered around its patented brain rejuvenation methods. Simultaneously, the business is implementing eco-friendly waste disposal standards in its laboratories to optimize water consumption. The high scientific value of these developments protects the company from market dumping, while the key metric stands at -0.00. The available price action vector for analysis is presented below.

WENA Anew Medical Book Capitalization (06/25/2024 - 09/17/2024)

For Anew Medical, Inc. (WENA), which develops unique gene therapy methods, the company's aggregate balance sheet capitalization reflects the resilience of its intellectual and material foundation under patent protection. This metric measures the real value of net assets through a daily recalculation of equity, where the stability of the indicator confirms the preservation of resources, and its growth signals an expansion of the asset base and the minimization of default risks.

Competitor analysis for Anew Medical, Inc.

BIIB - Accounting Capitalization|NBIX: Book Capitalization|RGC (regencellbioscience.com) - Book Capitalization|Company Book Value Axsome Therapeutics, Inc. (AXSM)|Accounting Capitalization ACADIA Pharma|Xenon Pharmaceuticals Inc - Book Capitalization|Total Stockholders' Equity Viking Therapeutics Corp VKTX|Company Net Assets SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Book Capitalization|Company Book Value Denali Therapeutics Inc. (DNLI)|HRMY: Accounting Value of Company|Company Book Value BHVN|Amylyx Corp (AMLX) - Total Stockholders' Equity|TRVI (Trevi Therapeutics) - Book Capitalization|Book Capitalization PRAX|Company Book Value Anavex Life Sciences Corp. AVXL|Accounting Capitalization CeriBell Inc (CBLL)|PRTA: Book Capitalization|ALEC - Total Stockholders' Equity|ANNX: Company Net Assets|Omeros Corporation (OMER) - Company Net Assets|Company Net Assets Neurogene NGNE|ACIU (AC Immune S.A.) - Accounting Value of Company|Company Book Value VYGR|Company Net Assets Neumora Corp|Scilex Holding Company - Book Capitalization|Total Stockholders' Equity tevogen.com (TVGN)|ACOG - Book Capitalization|Accounting Capitalization cogrx.com CGTX|Book Capitalization IKT (Inhibikase)|SAVA - Book Valuation of Business|ASRT (assertiotx.com) - Book Capitalization|Coya Therapeutics (COYA) - Company Net Assets|VTGN (VistaGen Therapeutics, Inc.) - Book Capitalization|Book Capitalization OVID|Company Book Value Acumen Pharma (ABOS)|Company Book Value CervoMed Corporation CRVO|Company Net Assets Alterity Therapeutics Limited|Accounting Value of Company Clene Inc CLNN|Book Capitalization PEPG (PepGen Corp)|JUNS: Book Valuation of Business|Company Book Value Relmada|Annovis Bio Corporation (ANVS) - Accounting Capitalization|Book Capitalization GRCE|Company Net Assets fireflyneuro.com (AIFF)|KLTO (Klotho Neurosciences Inc) - Company Net Assets|Book Valuation of Business neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings - Company Net Assets|Company Net Assets MetaVia Inc. MTVA|NRXS (NeurAxis, Inc.) - Book Capitalization|HSDT: Total Stockholders' Equity|Company Book Value passagebio.com|Neuphoria Therapeutics (NEUP) - Accounting Capitalization|NERV (Minerva Neurosciences Corp) - Book Capitalization|Book Capitalization ATHA|Company Book Value Addex Therapeutics ADXN|Accounting Capitalization alzamend.com (ALZN)|CYCN: Book Capitalization|PTIX - Total Stockholders' Equity|Pasithea - Company Net Assets|CRGT: Book Capitalization|Company Book Value Avenue Therapeutics ATXI|BCLI (brainstorm-cell.com) - Accounting Value of Company|Company Book Value CARA (Cara Therapeutics)|Total Stockholders' Equity Chromocell Therapeutics Corp|Book Capitalization ELYM|Book Capitalization ITCI (intracellulartherapies.com)|LBPH - Company Book Value|Accounting Capitalization marinuspharma.com MRNS|NKGN (NKGen Biotech) - Book Capitalization|NeuroBo Pharmaceuticals Inc (NRBO) - Total Stockholders' Equity|SAGE (Sage Therapeutics, Inc) - Company Net Assets|Company Net Assets Synaptogenix, Inc|TRVN - Company Net Assets|Accounting Value of Company VIGL|Company Book Value CERE (Cerevel Therapeutics, Inc.)